Consequently, the significant reduction in the expression of IGFBP-3 and IL-6, as a result of the inhibitory effects of these metabolites, leads to the emergence of abnormal blood glucose levels and the accompanying vasculopathy during the occurrence of diabetes in this study. This evidence concerns the gene IGFBP3 and diabetes mellitus.